ArticleCirculation. Cardiovascular quality and outcomes2021
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy.
Article in Circulation. Cardiovascular quality and outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Factors associated with patient preferences for statin therapy in primary prevention.American journal of preventive cardiology · 2026Article
- Discordance Between Perceived Risk and Cardiovascular Health in Women of Reproductive Age.JACC. Advances · 2026Article
- From Misperception to Prevention: Improving Cardiovascular Health and Risk Perception Through Risk Communication in Hungary.Healthcare (Basel, Switzerland) · 2026Article
- Validation of Risk Perception Cut-Offs in Italian Brief PRHDS (PRHDS-BI): Implications for Primary Cardiovascular Prevention.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026Observational
- Perceptions of ischaemic heart disease risk among Indian migrants in Australia: a qualitative study.Primary health care research & development · 2026Article
- Social Determinants of Health and Health Care Utilization among Hispanic and Non-Hispanic Black Men at Risk for Hypertension.Ethnicity & disease · 2025Article
- Risk of cardiovascular disease in Germany: results from GEDA 2022.Journal of health monitoring · 2025Article
- Cardiovascular magnetic resonance imaging markers of ageing: a multi-centre, cross-sectional cohort study.European heart journal open · 2025Article
- Discrepancies Between Physician-Perceived and Calculated Cardiovascular Risk in Primary Prevention: Implications for LDL-C Target Achievement and Appropriate Lipid-Lowering Therapy.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025Article
- Revealing the limitations of 10-year MACE observations: 20-year observed total cardiovascular burden in the EPIC-Norfolk study.Open heart · 2025Article
- Online Health Information Seeking: Implications for Self-Management in Hypertension.Risk management and healthcare policy · 2025Article
- Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis.Lipids in health and disease · 2024Article
- The impact of perception bias for cardiovascular disease risk on physical activity and dietary habits.International journal of nursing sciences · 2024Article
- Risk of Cardiovascular Events in Adults Aged 40 to 79 Years with Diagnosed Hypertension, High Cholesterol, and/or Diabetes but Not on Medications: Findings from Nationwide Cross-Sectional Studies.Journal of cardiovascular development and disease · 2024Article
- Patients' preferences for secondary prevention following a coronary event.Preventive medicine reports · 2024Article
- Article
- Effects of message framing and risk perception on health communication for optimum cardiovascular disease primary prevention: a protocol for a multicenter randomized controlled study.Frontiers in public health · 2024Article
- Motivational communication skills to improve motivation and adherence in cardiovascular disease prevention: A narrative review.Clinical cardiology · 2023Review
- Psychometric Properties of a Brief Version of the Perception of Risk of Heart Disease Scale in an Italian Sample.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023Article
- Associations among risk perception, health efficacy, and health behaviors for cardiovascular disease: an application of risk perception attitude framework.Frontiers in cardiovascular medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCardiovascular prevention guidelines use estimated 10-year atherosclerotic cardiovascular disease (CVD) risk based on the pooled cohort equations to guide treatment decisions and engage patients in shared decision-making. We sought to determine patient perceived versus actual risk of atherosclerotic CVD and associations with willingness for preventive therapy.
methodsWe evaluated calculated and perceived CVD risk among 4187 patients across 124 sites in the Patient and Provider Assessment of Lipid Management Registry. Ten-year risk was assessed using the pooled cohort equations; risk relative-to-peers was determined based on age-, sex-, and race-based percentiles; and patient estimates of risk were assessed using patient surveys. Poisson regression models evaluated associations between risk estimates, statin use, and willingness to take prevention therapy.
resultsOverall, there was no correlation between patients' estimates of their 10-year CVD risk and calculated 10-year risk (ρ=-0.01,
conclusionsWhen asked, most patients overestimate their 10-year risk but hold an optimistic bias of their risk relative to age-, race-, and sex-matched peers. Providing accurate absolute risk assessments to patients without proper context may paradoxically decrease many patients' perceived risk of CVD, thereby disincentivizing initiation of CVD risk reduction therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.